Haemonetics (HAE) Current Assets (2010 - 2026)

Haemonetics has reported Current Assets for 17 years, with the latest figure at $810.8 million in Q2 2026.

• On a quarterly basis, Current Assets fell 11.21% year-over-year to $810.8 million in Q2 2026; TTM through Jun 2026 was $810.8 million, a 11.21% decrease from a year earlier, with the FY2026 full-year figure at $834.9 million, down 10.71% from the prior year.
• Current Assets was $810.8 million for Q2 2026 at Haemonetics, down from $834.9 million in the prior quarter.
• The five-year high for Current Assets was $1.0 billion in Q4 2024, with the low at $687.8 million in Q3 2022.
• Average Current Assets over 5 years is $833.9 million, with a median of $810.8 million recorded in 2026.
• The sharpest annual moves came in 2024 and 2026: Current Assets jumped 31.49% in 2024, then decreased 11.21% in 2026.
• Over 5 years, Current Assets stood at $706.3 million in 2022, then gained by 8.31% to $765.0 million in 2023, then jumped by 31.49% to $1.0 billion in 2024, then declined by 6.18% to $943.7 million in 2025, then declined by 14.08% to $810.8 million in 2026.
• The last three Current Assets figures came in at $810.8 million (Q2 2026), $834.9 million (Q1 2026), and $943.7 million (Q4 2025), per Business Quant data.